Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Abstract

Nanomaterials (NMs) have garnered decades of research interest owing to their unique physicochemical properties and unparalleled advantages in diverse applications. However, these distinctive characteristics simultaneously raise concerns regarding their biosafety. Recent advancements in understanding NMs–organism interactions have led to innovative strategies for mitigating their intrinsic toxicity. Notably, emerging studies reveal that through rational design and precise manipulation, the inherent toxicological effects of NMs can be strategically repurposed for cancer therapeutics. For instance, functionalized NMs may disrupt oxidative homeostasis, activate programmed cell death pathways, modulate immune responses, or regulate ion channel activities. Despite these promising discoveries, the systematic exploitation of NMs-induced biological responses in oncological interventions remains underexplored. Therefore, this review provides, for the first time, a comprehensive introduction to NM-mediated biological process modulation, focusing on their mechanisms and therapeutic potential in cancer treatment. We have summarized (1) key pathways through which NMs elicit cytotoxic effects, including redox homeostasis regulation, immunogenic cell death activation, and so on; (2) design principles for engineering NMs with controllable bio-interactions; and (3) innovative applications leveraging NM-triggered physical effects (e.g., photothermal conversion, reactive oxygen species generation) as targeted therapeutic modalities. Furthermore, we also highlight the translational significance of harnessing NM-specific bioactivities while discussing current challenges in clinical adaptation and possible solutions. By bridging the gap between nanotoxicology and therapeutic innovation, this manuscript offers novel perspectives for developing next-generation nanomedicine platforms with enhanced efficacy and safety profiles.

Keywords

biological response / cancer inhibition / nano–bio interaction / nanomaterials / nanotoxicity

References

[1] W. Fan, B. Yung, P. Huang, and X. Chen, “Nanotechnology for Multimodal Synergistic Cancer Therapy,” Chemical Reviews 117 (2017): 13566-13638.

[2] A. K. Soni and R. K. Jha, “Nanotechnology's Applications and Potential in Various Fields,” Cureus 16 (2024): e59234.

[3] J. Nam, S. Son, K. S. Park, W. Zou, L. D. Shea, and J. J. Moon, “Cancer Nanomedicine for Combination Cancer Immunotherapy,” Nature Reviews Materials 4 (2019): 398-414.

[4] I. Brigger, C. Dubernet, and P. Couvreur, “Nanoparticles in Cancer Therapy and Diagnosis,” Advanced Drug Delivery Reviews 64 (2012): 24-36.

[5] B. R. Smith and S. S. Gambhir, “Nanomaterials for in Vivo Imaging,” Chemical Reviews 117 (2017): 901-986.

[6] R. Kumar, K. R. Aadil, S. Ranjan, and V. B. Kumar, “Advances in Nanotechnology and Nanomaterials Based Strategies for Neural Tissue Engineering,” Journal of Drug Delivery Science and Technology 57 (2020): 101617.

[7] H. Fu, C. Miao, Y. Rui, et al., “Strategy to Prevent Cardiac Toxicity Induced by Polyacrylic Acid Decorated Iron MRI Contrast Agent and Investigation of Its Mechanism,” Biomaterials 222 (2019): 119442.

[8] N. Prajitha, S. S. Athira, and P. V. Mohanan, “Bio-interactions and Risks of Engineered Nanoparticles,” Environmental Research 172 (2019): 98-108.

[9] B. Giese, F. Klaessig, B. Park, et al., “Risks, Release and Concentrations of Engineered Nanomaterial in the Environment,” Scientific Reports 8 (2018): 1565.

[10] X. Lu, Y. Zhu, R. Bai, et al., “Long-term Pulmonary Exposure to Multi-walled Carbon Nanotubes Promotes Breast Cancer Metastatic Cascades,” Nature Nanotechnology 14 (2019): 719-727.

[11] X. Xue, J.-Y. Yang, Y. He, et al., “Aggregated Single-walled Carbon Nanotubes Attenuate the Behavioural and Neurochemical Effects of Methamphetamine in Mice,” Nature Nanotechnology 11 (2016): 613-620.

[12] C. Chung, Y.-K. Kim, D. Shin, S.-R. Ryoo, B. H. Hong, and D.-H. Min, “Biomedical Applications of Graphene and Graphene Oxide,” Accounts of Chemical Research 46 (2013): 2211-2224.

[13] S. Sharifi, S. Behzadi, S. Laurent, M. L. Forrest, P. Stroeve, and M. Mahmoudi, “Toxicity of Nanomaterials,” Chemical Society Reviews 41 (2012): 2323-2343.

[14] S. J. Soenen, P. Rivera-Gil, J.-M. Montenegro, W. J. Parak, S. C. De Smedt, and K. Braeckmans, “Cellular Toxicity of Inorganic Nanoparticles: Common Aspects and Guidelines for Improved Nanotoxicity Evaluation,” Nano Today 6 (2011): 446-465.

[15] S. Tohme, R. L. Simmons, and A. Tsung, “Surgery for Cancer: A Trigger for Metastases,” Cancer Research 77 (2017): 1548-1552.

[16] N. Behranvand, F. Nasri, R. Zolfaghari Emameh, et al., “Chemotherapy: A Double-Edged Sword in Cancer Treatment,” Cancer Immunology, Immunotherapy 71 (2022): 507-526.

[17] C. Honoré, K. Amroun, L. Vilcot, et al., “Abdominal Desmoplastic Small Round Cell Tumor: Multimodal Treatment Combining Chemotherapy, Surgery, and Radiotherapy Is the Best Option,” Annals of Surgical Oncology 22 (2015): 1073-1079.

[18] Y. Sun, C. Kang, A. Zhang, et al., “Co-delivery of Dual-drugs With Nanoparticle to Overcome Multidrug Resistance,” European Journal of Biomedical Research 2 (2016): 12.

[19] C. S. Cutler, H. M. Hennkens, N. Sisay, S. Huclier-Markai, and S. S. Jurisson, “Radiometals for Combined Imaging and Therapy,” Chemical Reviews 113 (2013): 858-883.

[20] D. Schaue and W. H. McBride, “Opportunities and Challenges of Radiotherapy for Treating Cancer,” Nature Reviews Clinical Oncology 12 (2015): 527-540.

[21] G. Liu, T. Chen, X. Zhang, X. Ma, and H. Shi, “Small Molecule Inhibitors Targeting the Cancers,” MedComm 3 (2022): e181.

[22] A. C. Martins, M. Y. Oshiro, F. Albericio, and B. G. de la Torre, “Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023,” Biomedicines 12 (2024): 1992.

[23] K. Esfahani, L. Roudaia, N. Buhlaiga, S. V. Del Rincon, N. Papneja, and W. H. Miller, “A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future,” Current Oncology 27 (2020): 87-97.

[24] X. Shan, X. Gong, J. Li, J. Wen, Y. Li, and Z. Zhang, “Current Approaches of Nanomedicines in the Market and Various Stage of Clinical Translation,” Acta Pharmaceutica Sinica B 12 (2022): 3028-3048.

[25] F. Rodríguez, P. Caruana, N. De la Fuente, et al., “Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges,” Biomolecules 12 (2022): 784.

[26] Y. Min, J. M. Caster, M. J. Eblan, and A. Z. Wang, “Clinical Translation of Nanomedicine,” Chemical Reviews 115 (2015): 11147-11190.

[27] P. Cai, X. Zhang, M. Wang, Y.-L. Wu, and X. Chen, “Combinatorial Nano-Bio Interfaces,” ACS Nano 12 (2018): 5078-5084.

[28] M. Sajid, M. Ilyas, C. Basheer, et al., “Impact of Nanoparticles on Human and Environment: Review of Toxicity Factors, Exposures, Control Strategies, and Future Prospects,” Environmental Science and Pollution Research 22 (2015): 4122-4143.

[29] H. Lei, Z. Pei, C. Jiang, and L. Cheng, “Recent Progress of Metal-Based Nanomaterials With Anti-Tumor Biological Effects for Enhanced Cancer Therapy,” Exploration 3 (2023): 20220001.

[30] H. Sies, V. V. Belousov, N. S. Chandel, et al., “Defining Roles of Specific Reactive Oxygen Species (ROS) in Cell Biology and Physiology,” Nature Reviews Molecular Cell Biology 23 (2022): 499-515.

[31] S. Yang and G. Lian, “ROS and Diseases: Role in Metabolism and Energy Supply,” Molecular and Cellular Biochemistry 467 (2020): 1-12.

[32] B. Perillo, M. Di Donato, A. Pezone, et al., “ROS in Cancer Therapy: The Bright Side of the Moon,” Experimental & Molecular Medicine 52 (2020): 192-203.

[33] B. Yang, Y. Chen, and J. Shi, “Reactive Oxygen Species (ROS)-Based Nanomedicine,” Chemical Reviews 119 (2019): 4881-4985.

[34] J. Wu, Y. Meng, F. Wu, et al., “Ultrasound-Driven Non-Metallic Fenton-Active Center Construction for Extensive Chemodynamic Therapy,” Advanced Materials 36 (2024): 2307980.

[35] Y. Zhang, N. Zhang, J. Xing, et al., “In Situ Hydrogel Based on Cu-Fe3O4 Nanoclusters Exploits Oxidative Stress and the Ferroptosis/Cuproptosis Pathway for Chemodynamic Therapy,” Biomaterials 311 (2024): 122675.

[36] M. Yu, Z. Ye, S. Liu, et al., “Redox-Active Ferrocene Quencher-Based Supramolecular Nanomedicine for NIR-II Fluorescence-Monitored Chemodynamic Therapy,” Angewandte Chemie International Edition 63 (2024): e202318155.

[37] L.-H. Xiong, L. Yang, J. Geng, B. Z. Tang, and X. He, “All-in-One Alkaline Phosphatase-Response Aggregation-Induced Emission Probe for Cancer Discriminative Imaging and Combinational Chemodynamic-Photodynamic Therapy,” ACS Nano 18 (2024): 17837-17851.

[38] J. Tang, Y. Liu, Y. Xue, Z. Jiang, B. Chen, and J. Liu, “Endoperoxide-Enhanced Self-Assembled ROS Producer as Intracellular Prodrugs for Tumor Chemotherapy and Chemodynamic Therapy,” Exploration 4 (2024): 20230127.

[39] Y. Chen, Z. Zhu, Y. Tian, and L. Jiang, “Rational Ion Transport Management Mediated through Membrane Structures,” Exploration 1 (2021): 20210101.

[40] M. Yavuz and T. Demircan, “A Potent Ion Channel Blocker, Hydroquinidine, Exhibits Strong Anti-cancer Activity on Colon, Pancreatic, and Hepatocellular Cancer Cells,” Molecular Biology Reports 50 (2023): 2611-2621.

[41] K. Yusa and T. Tsuruo, “Reversal Mechanism of Multidrug Resistance by Verapamil: Direct Binding of Verapamil to P-Glycoprotein on Specific Sites and Transport of Verapamil Outward Across the Plasma Membrane of K562/ADM Cells,” Cancer Research 49 (1989): 5002-5006.

[42] C. Stock and L. A. Pardo, Targets of Cancer Diagnosis and Treatment: Ion Transport in Tumor Biology (Springer Nature, 2022).

[43] R. J. DeBerardinis, C. B. Thompson, in Mol. Basis Cancer, ThirdEd. (Eds.: J. Mendelsohn, P. M. Howley, M. A. Israel, J. W. Gray, C. B. Thompson), and W. B. Saunders. ThirdEd. (Philadelphia 2008): 189-203.

[44] R. A. Cairns, I. S. Harris, and T. W. Mak, “Regulation of Cancer Cell Metabolism,” Nature Reviews Cancer 11 (2011): 85-95.

[45] A. Martín-Pardillos and P. Martin-Duque, “Cellular Alterations in Carbohydrate and Lipid Metabolism due to Interactions with Nanomaterials,” Journal of Functional Biomaterials 14 (2023): 274.

[46] C. M. Pfeffer and A. T. K. Singh, “Apoptosis: A Target for Anticancer Therapy,” International Journal of Molecular Sciences 19 (2018): 448.

[47] B. A. Carneiro and W. S. El-Deiry, “Targeting Apoptosis in Cancer Therapy,” Nature Reviews Clinical Oncology 17 (2020): 395-417.

[48] R. Jan and G.-S. Chaudhry, “Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics,” Advanced Pharmaceutical Bulletin 9 (2019): 205-218.

[49] F. T. Andón and B. Fadeel, “Programmed Cell Death: Molecular Mechanisms and Implications for Safety Assessment of Nanomaterials,” Accounts of Chemical Research 46 (2013): 733-742.

[50] D. J. Klionsky, G. Petroni, R. K. Amaravadi, et al., “Autophagy in Major human Diseases,” Embo Journal 40 (2021): e108863.

[51] X. Li, S. He, and B. Ma, “Autophagy and Autophagy-related Proteins in Cancer,” Molecular Cancer 19 (2020): 12.

[52] N. Mizushima, “Autophagy: Process and Function,” Genes & Development 21 (2007): 2861-2873.

[53] J. M. M. Levy, C. G. Towers, and A. Thorburn, “Targeting Autophagy in Cancer,” Nature Reviews Cancer 17 (2017): 528-542.

[54] L. Ding, Q. Wang, M. Shen, et al., “Thermoresponsive Nanocomposite Gel for Local Drug Delivery to Suppress the Growth of Glioma by Inducing Autophagy,” Autophagy 13 (2017): 1176-1190.

[55] Y.-Q. Zhao, L. Yu, L. Zhang, H. Liu, Y. Zhou, and J. S. Kim, “Activated Aggregation-Induced Emission Therapeutics Agents for Triggering Regulated Cell Death,” Aggregate 5 (2024): e503.

[56] X. Yang, M. Zhao, Z. Wu, et al., “Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy,” ACS Nano 16 (2022): 3417-3431.

[57] J. Li, F. Cao, H. Yin, et al., “Ferroptosis: Past, Present and Future,” Cell Death & Disease 11 (2020): 88.

[58] S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, et al., “Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death,” Cell 149 (2012): 1060-1072.

[59] B. R. Stockwell, J. P. F. Angeli, H. Bayir, et al., “Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease,” Cell 171 (2017): 273-285.

[60] W. S. Yang and B. R. Stockwell, “Ferroptosis: Death by Lipid Peroxidation,” Trends in Cell Biology 26 (2016): 165-176.

[61] L. Wang, H. Fu, L. Song, et al., “Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP-DRI-12,” Small 19 (2023): 2204133.

[62] Y. Qiu, Z. Wu, Y. Chen, et al., “Nano Ultrasound Contrast Agent for Synergistic Chemo-Photothermal Therapy and Enhanced Immunotherapy against Liver Cancer and Metastasis,” Advanced Science 10 (2023): 2300878.

[63] K. Li, S. Wang, C. Chen, et al., “Endowing 1T′-ReS 2 Nanosheets with Sonopiezoelectric Property by Theoretical-Guided Vacancy-Manipulated Peierls Distortion for Tumor Ferroptosis Therapy,” Journal of the American Chemical Society 146 (2024): 27779-27793.

[64] J. Zhao, E. Bian, R. Zhang, et al., “Self-Assembled Aza-Boron-Dipyrromethene-Based H 2 S Prodrug for Synergistic Ferroptosis-Enabled Gas and Sonodynamic Tumor Therapies,” Advanced Science 11 (2024): 2309542.

[65] Z. Wang, X. Wang, X. Dai, et al., “2D Catalytic Nanozyme Enables Cascade Enzyodynamic Effect-Boosted and Ca 2+ Overload-Induced Synergistic Ferroptosis/Apoptosis in Tumor,” Advanced Materials 36 (2024): 2312316.

[66] P. Tsvetkov, S. Coy, B. Petrova, et al., “Copper Induces Cell Death by Targeting Lipoylated TCA Cycle Proteins,” Science 375 (2022): 1254-1261.

[67] Y. Wang, L. Zhang, and F. Zhou, “Cuproptosis: A New Form of Programmed Cell Death,” Cellular & Molecular Immunology 19 (2022): 867-868.

[68] S.-R. Li, L.-L. Bu, and L. Cai, “Cuproptosis: Lipoylated TCA Cycle Proteins-Mediated Novel Cell Death Pathway,” Signal Transduction and Targeted Therapy 7 (2022): 158.

[69] C. Wei and Q. Fu, “Cell Death Mediated by Nanotechnology via the Cuproptosis Pathway: A Novel Horizon for Cancer Therapy,” VIEW 4 (2023): 20230001.

[70] S. Ning, M. Lyu, D. Zhu, et al., “Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge,” ACS Nano 17 (2023): 10206-10217.

[71] M.-T. Niu, Q.-R. Li, Q.-X. Huang, et al., “Amplifying Synergistic Effects of Cuproptosis and Bacterial Membrane Vesicles-Mediated Photothermal Therapy by Multifunctional Nano-Biohybrid for Anti-Tumor Immunotherapy,” Advanced Functional Materials 35 (2025): 2413255.

[72] H. Zhang, F. Chen, W. Cheng, et al., “Dynamic Polyphenol Nanoparticles Boost Cuproptosis-driven Metalloimmunotherapy of Breast Cancer,” Nano Today 58 (2024): 102442.

[73] Y. Zhu, X. Niu, C. Ding, et al., “Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy,” Advanced Science 11 (2024): 2402516.

[74] L. Yang, Z. Zhao, B. Tian, et al., “A Singular Plasmonic-thermoelectric Hollow Nanostructure Inducing Apoptosis and Cuproptosis for Catalytic Cancer Therapy,” Nature Communications 15 (2024): 7499.

[75] P. Yu, X. Zhang, N. Liu, L. Tang, C. Peng, and X. Chen, “Pyroptosis: Mechanisms and Diseases,” Signal Transduction and Targeted Therapy 6 (2021): 128.

[76] D. Wu, S. Wang, G. Yu, and X. Chen, “Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy,” Angewandte Chemie 133 (2021): 8096-8112.

[77] R. K. S. Malireddi, S. Kesavardhana, and T.-D. Kanneganti, “ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis),” Frontiers in Cellular and Infection Microbiology 9 (2019): 406.

[78] C. Shi, P. Cao, Y. Wang, et al., “PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis,” Journal of Inflammation Research 16 (2023): 1523-1532.

[79] G. Hou, Y. Chen, H. Lei, S. Lu, and L. Cheng, “Nanomaterials-Induced PANoptosis: A Promising anti-Tumor Strategy,” Angewandte Chemie 137 (2025): e202419649.

[80] D. K. W. Ocansey, F. Qian, P. Cai, et al., “Current Evidence and Therapeutic Implication of PANoptosis in Cancer,” Theranostics 14 (2024): 640-661.

[81] J. Zhang, Y. Hu, X. Wen, et al., “Tandem-Controlled Lysosomal Assembly of Nanofibres Induces Pyroptosis for Cancer Immunotherapy,” Nature Nanotechnology 20 (2025): 563-574.

[82] J. Xing, X. Ma, Y. Yu, et al., “A Cardiac-Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy-Induced Cardiac Ferroptosis and PANoptosis,” Advanced Science 12 (2025): 2405597.

[83] M. Abbott and Y. Ustoyev, “Cancer and the Immune System: The History and Background of Immunotherapy,” Seminars in Oncology Nursing 35 (2019): 150923.

[84] M. A. Dobrovolskaia, “Pre-clinical Immunotoxicity Studies of Nanotechnology-formulated Drugs: Challenges, Considerations and Strategy,” Journal of Controlled Release 220 (2015): 571-583.

[85] W. J. Gradishar, S. Tjulandin, N. Davidson, et al., “Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared with Polyethylated Castor Oil-Based Paclitaxel in Women with Breast Cancer,” Journal of Clinical Oncology 23 (2005): 7794-7803.

[86] W. Song, S. N. Musetti, and L. Huang, “Nanomaterials for Cancer Immunotherapy,” Biomaterials 148 (2017): 16-30.

[87] X. Zhu and S. Li, “Nanomaterials in Tumor Immunotherapy: New Strategies and Challenges,” Molecular Cancer 22 (2023): 94.

[88] T. Wu and Y. Dai, “Tumor Microenvironment and Therapeutic Response,” Cancer Letters 387 (2017): 61-68.

[89] S. Thakkar, D. Sharma, K. Kalia, and R. K. Tekade, “Tumor Microenvironment Targeted Nanotherapeutics for Cancer Therapy and Diagnosis: A Review,” Acta Biomaterialia 101 (2020): 43-68.

[90] N. M. Anderson and M. C. Simon, “The Tumor Microenvironment,” Current Biology 30 (2020): R921-R925.

[91] J. Du, L. A. Lane, and S. Nie, “Stimuli-responsive Nanoparticles for Targeting the Tumor Microenvironment,” Journal of Controlled Release 219 (2015): 205-214.

[92] A. Wicki, D. Witzigmann, V. Balasubramanian, and J. Huwyler, “Nanomedicine in Cancer Therapy: Challenges, Opportunities, and Clinical Applications,” Journal of Controlled Release 200 (2015): 138-157.

[93] S. Klein, J. Otto, C. Harreiß, et al., “Pt-Fe 3 O 4, Pd-Fe 3 O 4, and Au-Fe 3 O 4 Nanoheterodimers and Their Efficacy as Radiosensitizers in Cancer Therapy,” American Chemical Society Applied Bio Materials 4 (2021): 7879-7892.

[94] M. Q. Al-Fahdawi, F. A. J. Al-Doghachi, Q. K. Abdullah, et al., “Oxidative Stress Cytotoxicity Induced by Platinum-doped Magnesia Nanoparticles in Cancer Cells,” Biomedicine & Pharmacotherapy 138 (2021): 111483.

[95] H. Zhang, W. Zhang, B. Hu, et al., “Precise Pancreatic Cancer Therapy through Targeted Degradation of Mutant p53 Protein by Cerium Oxide Nanoparticles,” Journal of Nanobiotechnology 21 (2023): 117.

[96] Z. Hu and Y. Ding, “Cerium Oxide Nanoparticles-mediated Cascade Catalytic Chemo-photo Tumor Combination Therapy,” Nano Research 15 (2022): 333-345.

[97] Q. Wang, Y. Sun, Z. Zhang, and Y. Duan, “Targeted Polymeric Therapeutic Nanoparticles: Design and Interactions with Hepatocellular Carcinoma,” Biomaterials 56 (2015): 229-240.

[98] Q. Wang, X. Zhang, Y. Sun, et al., “Gold-caged Copolymer Nanoparticles as Multimodal Synergistic Photodynamic/Photothermal/Chemotherapy Platform against Lethality Androgen-resistant Prostate Cancer,” Biomaterials 212 (2019): 73-86.

[99] B. Li, S. Ren, D. Gao, et al., “Photothermal Conjugated Polymer Nanoparticles for Suppressing Breast Tumor Growth by Regulating TRPA1 Ion Channels,” Advanced Healthcare Materials 11 (2022): 2102506.

[100] L. Zhang, Z. Wang, Y. Zhang, et al., “Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy,” American Chemical Society Nano 12 (2018): 10201-10211.

[101] B. Yang, L. Ding, Y. Chen, and J. Shi, “Augmenting Tumor-Starvation Therapy by Cancer Cell Autophagy Inhibition,” Advanced Science 7 (2020): 1902847.

[102] S. Wu, K. Zhang, Y. Liang, et al., “Nano-Enabled Tumor Systematic Energy Exhaustion via Zinc (II) Interference Mediated Glycolysis Inhibition and Specific GLUT1 Depletion,” Advanced Science 9 (2022): 2103534.

[103] J. Zhu, H. Cai, C. Xu, et al., “Acidity-Responsive Nanoreactors Destructed “Warburg Effect” for Toxic-Acidosis and Starvation Synergistic Therapy,” Small 19 (2023): 2304058.

[104] J. Zhai, Y. Jia, L. Zhao, et al., “Turning on/off the Anti-Tumor Effect of the Au Cluster via Atomically Controlling Its Molecular Size,” American Chemical Society Nano 12 (2018): 4378-4386.

[105] Q. Yang, Y. Wang, Q. Yang, et al., “Cuprous Oxide Nanoparticles Trigger ER Stress-induced Apoptosis by Regulating Copper Trafficking and Overcoming Resistance to Sunitinib Therapy in Renal Cancer,” Biomaterials 146 (2017): 72-85.

[106] Y. Wang, J. Wang, H. Hao, et al., “In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles,” American Chemical Society Nano 10 (2016): 9927-9937.

[107] X. Li, Y. Wang, Y. Chen, et al., “Hierarchically Constructed Selenium-doped Bone-mimetic Nanoparticles Promote ROS-mediated Autophagy and Apoptosis for Bone Tumor Inhibition,” Biomaterials 257 (2020): 120253.

[108] J. Liu, T. Liu, P. Du, L. Zhang, and J. Lei, “Metal-Organic Framework (MOF) Hybrid as a Tandem Catalyst for Enhanced Therapy against Hypoxic Tumor Cells,” Angewandte Chemie 131 (2019): 7890-7894.

[109] Y. Wang, Y.-X. Lin, Z.-Y. Qiao, et al., “Self-Assembled Autophagy-Inducing Polymeric Nanoparticles for Breast Cancer Interference in-Vivo,” Advanced Materials 27 (2015): 2627-2634.

[110] Y. Shang, Q. Wang, B. Wu, et al., “Platelet-Membrane-Camouflaged Black Phosphorus Quantum Dots Enhance Anticancer Effect Mediated by Apoptosis and Autophagy,” ACS Applied Materials & Interfaces 11 (2019): 28254-28266.

[111] K.-B. Huang, F.-Y. Wang, X.-M. Tang, et al., “Organometallic Gold(III) Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosis and Pro-Death Autophagy in A549 Cancer Cells,” Journal of Medicinal Chemistry 61 (2018): 3478-3490.

[112] X. Wang, M. Li, K. Ren, et al., “On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy,” Advanced Materials 32 (2020): 2002160.

[113] H.-Y. Wan, J.-L. Chen, X. Zhu, L. Liu, J. Wang, and X.-M. Zhu, “Titania-Coated Gold Nano-Bipyramids for Blocking Autophagy Flux and Sensitizing Cancer Cells to Proteasome Inhibitor-Induced Death,” Advanced Science 5 (2018): 1700585.

[114] Y. Zhang, R. Sha, L. Zhang, et al., “Harnessing Copper-palladium Alloy Tetrapod Nanoparticle-induced Pro-survival Autophagy for Optimized Photothermal Therapy of Drug-resistant Cancer,” Nature Communications 9 (2018): 4236.

[115] B. Kwon, E. Han, W. Yang, et al., “Nano-Fenton Reactors as a New Class of Oxidative Stress Amplifying Anticancer Therapeutic Agents,” ACS Applied Materials & Interfaces 8 (2016): 5887-5897.

[116] X. Meng, J. Deng, F. Liu, et al., “Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy,” Nano Letters 19 (2019): 7866-7876.

[117] V. Trujillo-Alonso, E. C. Pratt, H. Zong, et al., “FDA-approved Ferumoxytol Displays Anti-leukaemia Efficacy against Cells with Low Ferroportin Levels,” Nature Nanotechnology 14 (2019): 616-622.

[118] X. Meng, D. Li, L. Chen, et al., “High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy,” American Chemical Society Nano 15 (2021): 5735-5751.

[119] F. Zhang, F. Li, G.-H. Lu, et al., “Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer,” American Chemical Society Nano 13 (2019): 5662-5673.

[120] F. Zeng, L. Tang, Q. Zhang, et al., “Coordinating the Mechanisms of Action of Ferroptosis and the Photothermal Effect for Cancer Theranostics,” Angewandte Chemie 134 (2022): e202112925.

[121] W. Xu, Y. Wang, G. Hou, et al., “Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy,” Advanced Healthcare Materials 12 (2023): 2202949.

[122] B. Guo, F. Yang, L. Zhang, et al., “Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy,” Advanced Materials 35 (2023): 2212267.

[123] J. Zhou, Q. Yu, J. Song, et al., “Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy,” Angewandte Chemie International Edition 62 (2023): e202213922.

[124] Y. Lu, Q. Pan, W. Gao, Y. Pu, and B. He, “Reversal of Cisplatin Chemotherapy Resistance by Glutathione-resistant Copper-based Nanomedicine via Cuproptosis,” Journal of Materials Chemistry B 10 (2022): 6296-6306.

[125] J. Hu, Y. Dong, L. Ding, et al., “Local Delivery of Arsenic Trioxide Nanoparticles for Hepatocellular Carcinoma Treatment,” Signal Transduction and Targeted Therapy 4 (2019): 28.

[126] J.-X. Fan, R.-H. Deng, H. Wang, et al., “Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic Nanocarriers,” Nano Letters 19 (2019): 8049-8058.

[127] Q. Wang, Y. Wang, J. Ding, et al., “A Bioorthogonal System Reveals Antitumour Immune Function of Pyroptosis,” Nature 579 (2020): 421-426.

[128] L. Zhou, J. Lyu, F. Liu, Y. Su, L. Feng, and X. Zhang, “Immunogenic PANoptosis-Initiated Cancer Sono-Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle,” Advanced Materials 36 (2024): 2305361.

[129] X. Xu, S. Shabiti, X. Zhang, et al., “Membrane-anchoring Clickable Iridium(III) Nanosonosensitizer in Situ Evokes PANoptosis for Augmented Tumor Sono-immunotherapy,” Nano Today 56 (2024): 102270.

[130] S. Zanganeh, G. Hutter, R. Spitler, et al., “Iron Oxide Nanoparticles Inhibit Tumour Growth by Inducing Pro-inflammatory Macrophage Polarization in Tumour Tissues,” Nature Nanotechnology 11 (2016): 986-994.

[131] S. Chen, Z. Xing, M. Geng, et al., “Macrophage Fusion Event as One Prerequisite for Inorganic Nanoparticle-induced Antitumor Response,” Science Advances 9 (2023): eadd9871.

[132] H. Jiang, Y. Guo, C. Wei, P. Hu, and J. Shi, “Nanocatalytic Innate Immunity Activation by Mitochondrial DNA Oxidative Damage for Tumor-Specific Therapy,” Advanced Materials 33 (2021): 2008065.

[133] K.-S. Kim, J.-H. Han, J.-H. Park, et al., “Multifunctional Nanoparticles for Genetic Engineering and Bioimaging of Natural Killer (NK) Cell Therapeutics,” Biomaterials 221 (2019): 119418.

[134] H. Jiang, H. Fu, T. Min, P. Hu, and J. Shi, “Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic Liver Cancer,” Journal of the American Chemical Society 145 (2023): 13147-13160.

[135] J. Pan, Y. Xu, Q. Wu, P. Hu, and J. Shi, “Mild Magnetic Hyperthermia-Activated Innate Immunity for Liver Cancer Therapy,” Journal of the American Chemical Society 143 (2021): 8116-8128.

[136] J. Chen, Z. Ye, C. Huang, et al., “Lipid Nanoparticle-mediated Lymph Node-targeting Delivery of mRNA Cancer Vaccine Elicits Robust CD8 + T Cell Response,” Proceedings of the National Academy of Sciences of the United States of America 119 (2022): e2207841119.

[137] T. T. Smith, S. B. Stephan, H. F. Moffett, et al., “In Situ Programming of Leukaemia-specific T Cells Using Synthetic DNA Nanocarriers,” Nature Nanotechnology 12 (2017): 813-820.

[138] L. Tang, Y. Zheng, M. B. Melo, et al., “Enhancing T Cell Therapy through TCR-signaling-responsive Nanoparticle Drug Delivery,” Nature Biotechnology 36 (2018): 707-716.

[139] Y. Huang, Y. Chen, S. Zhou, et al., “Dual-mechanism Based CTLs Infiltration Enhancement Initiated by Nano-sapper Potentiates Immunotherapy against Immune-excluded Tumors,” Nature Communications 11 (2020): 622.

[140] Y. Ma, Y. Zhang, X. Li, et al., “Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy,” American Chemical Society Nano 13 (2019): 11967-11980.

[141] J. Nam, S. Son, L. J. Ochyl, R. Kuai, A. Schwendeman, and J. J. Moon, “Chemo-photothermal Therapy Combination Elicits Anti-tumor Immunity against Advanced Metastatic Cancer,” Nature Communications 9 (2018): 1074.

[142] B. Zhou, Q. Wu, M. Wang, et al., “Immunologically Modified MnFe2O4 Nanoparticles to Synergize Photothermal Therapy and Immunotherapy for Cancer Treatment,” Chemical Engineering Journal 396 (2020): 125239.

[143] M. Guan, Y. Zhou, S. Liu, et al., “Photo-triggered Gadofullerene: Enhanced Cancer Therapy by Combining Tumor Vascular Disruption and Stimulation of Anti-tumor Immune Responses,” Biomaterials 213 (2019): 119218.

[144] J. Chen, L. Feng, P. Jin, et al., “Cavitation Assisted Endoplasmic Reticulum Targeted Sonodynamic Droplets to Enhanced Anti-PD-L1 Immunotherapy in Pancreatic Cancer,” Journal of Nanobiotechnology 20 (2022): 283.

[145] Z. Liu, J. Li, Y. Jiang, and D. Wang, “Multifunctional Nanocapsules on a Seesaw Balancing Sonodynamic and Photodynamic Therapies against Superficial Malignant Tumors by Effective Immune-enhancement,” Biomaterials 218 (2019): 119251.

[146] J. Pan, P. Hu, Y. Guo, et al., “Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments,” American Chemical Society Nano 14 (2020): 1033-1044.

[147] H. Fu, L. Chen, W. Fang, P. Hu, and J. Shi, “Mild Magnetothermal Enhanced Nanocatalytic Immunotherapy for Solid Tumors by Immune Cell Activation and Intratumoral Infiltration,” Nano Today 52 (2023): 101987.

[148] H. Jiang, Q. Wang, L. Li, et al., “Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8 + T Cell Responses,” Advanced Science 5 (2018): 1700426.

[149] W. Chen, M. Qin, X. Chen, Q. Wang, Z. Zhang, and X. Sun, “Combining Photothermal Therapy and Immunotherapy against Melanoma by Polydopamine-coated Al2O3 Nanoparticles,” Theranostics 8 (2018): 2229-2241.

[150] X. Zhong, Y. Zhang, L. Tan, et al., “An Aluminum Adjuvant-integrated Nano-MOF as Antigen Delivery System to Induce Strong Humoral and Cellular Immune Responses,” Journal of Controlled Release 300 (2019): 81-92.

[151] Z. Wang, Y. Zhang, E. Ju, et al., “Biomimetic Nanoflowers by Self-assembly of Nanozymes to Induce Intracellular Oxidative Damage against Hypoxic Tumors,” Nature Communications 9 (2018): 3334.

[152] X. Liu, Y. Pan, J. Yang, et al., “Gold Nanoparticles Doped Metal-organic Frameworks as near-infrared Light-enhanced Cascade Nanozyme against Hypoxic Tumors,” Nano Research 13 (2020): 653-660.

[153] F. Cao, Y. Zhang, Y. Sun, et al., “Ultrasmall Nanozymes Isolated within Porous Carbonaceous Frameworks for Synergistic Cancer Therapy: Enhanced Oxidative Damage and Reduced Energy Supply,” Chemistry of Materials 30 (2018): 7831-7839.

[154] X. Luan, Y.-Y. Guan, J. F. Lovell, et al., “Tumor Priming Using Metronomic Chemotherapy with Neovasculature-targeted, Nanoparticulate Paclitaxel,” Biomaterials 95 (2016): 60-73.

[155] L. Miao, Q. Liu, C. M. Lin, et al., “Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors,” Cancer Research 77 (2017): 719-731.

[156] A. Zinger, L. Koren, O. Adir, et al., “Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors,” American Chemical Society Nano 13 (2019): 11008-11021.

[157] H. Gong, Y. Chao, J. Xiang, et al., “Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy,” Nano Letters 16 (2016): 2512-2521.

[158] L. Zhang, Y. Jia, J. Yang, et al., “Efficient Immunotherapy of Drug-Free Layered Double Hydroxide Nanoparticles via Neutralizing Excess Acid and Blocking Tumor Cell Autophagy,” American Chemical Society Nano 16 (2022): 12036-12048.

[159] L. Zhang, J. Zhao, X. Hu, et al., “A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors,” Advanced Materials 34 (2022): 2206915.

[160] B. Ding, P. Zheng, J. Tan, et al., “Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism,” Angewandte Chemie 135 (2023): e202307706.

[161] J. Qi, G. Jiang, Y. Wan, J. Liu, and F. Pi, “Nanomaterials-modulated Fenton Reactions: Strategies, Chemodynamic Therapy and Future Trends,” Chemical Engineering Journal 466 (2023): 142960.

[162] T. Mai and J. Z. Hilt, “Magnetic Nanoparticles: Reactive Oxygen Species Generation and Potential Therapeutic Applications,” Journal of Nanoparticle Research 19 (2017): 253.

[163] M. Ahamed, M. A. M. Khan, M. J. Akhtar, H. A. Alhadlaq, and A. Alshamsan, “Role of Zn Doping in Oxidative Stress Mediated Cytotoxicity of TiO2 Nanoparticles in human Breast Cancer MCF-7 Cells,” Scientific Reports 6 (2016): 30196.

[164] Z. Jin, Y. Wen, L. Xiong, et al., “Intratumoral H 2 O 2 -triggered Release of CO From a Metal Carbonyl-based Nanomedicine for Efficient CO Therapy,” Chemical Communications 53 (2017): 5557-5560.

[165] Y. Wang, T. Yang, and Q. He, “Strategies for Engineering Advanced Nanomedicines for Gas Therapy of Cancer,” National Science Review 7 (2020): 1485-1512.

[166] J. Jiang, H. Zheng, Z. Wang, et al., “Intracellular Dehydrogenation Catalysis Leads to Reductive Stress and Immunosuppression,” Nature Nanotechnology 20 (2025): 554-562.

[167] Q. Huang, W. Zhu, X. Gao, X. Liu, Z. Zhang, and B. Xing, “Nanoparticles-mediated Ion Channels Manipulation: From Their Membrane Interactions to Bioapplications,” Advanced Drug Delivery Reviews 195 (2023): 114763.

[168] A. Leifert, Y. Pan, A. Kinkeldey, et al., “Differential hERG Ion Channel Activity of Ultrasmall Gold Nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America 110 (2013): 8004-8009.

[169] M. Zhou, B. Li, N. Li, M. Li, and C. Xing, “Regulation of Ca 2+ for Cancer Cell Apoptosis Through Photothermal Conjugated Nanoparticles,” American Chemical Society Applied Bio Materials 5 (2022): 2834-2842.

[170] Y. Lyu, C. Xie, S. A. Chechetka, E. Miyako, and K. Pu, “Semiconducting Polymer Nanobioconjugates for Targeted Photothermal Activation of Neurons,” Journal of the American Chemical Society 138 (2016): 9049-9052.

[171] N. Li, Y. Gao, B. Li, et al., “Remote Manipulation of ROS-Sensitive Calcium Channel Using Near-Infrared-Responsive Conjugated Oligomer Nanoparticles for Enhanced Tumor Therapy in Vivo,” Nano Letters 22 (2022): 5427-5433.

[172] S. Siemer, T. A. Bauer, P. Scholz, et al., “Targeting Cancer Chemotherapy Resistance by Precision Medicine-Driven Nanoparticle-Formulated Cisplatin,” American Chemical Society Nano 15 (2021): 18541-18556.

[173] H. Kang, K. Zhang, D. S. H. Wong, F. Han, B. Li, and L. Bian, “Near-infrared Light-controlled Regulation of Intracellular Calcium to Modulate Macrophage Polarization,” Biomaterials 178 (2018): 681-696.

[174] Z. Gu and C. Yu, “Harnessing Bioactive Nanomaterials in Modulating Tumor Glycolysis-associated Metabolism,” Journal of Nanobiotechnology 20 (2022): 528.

[175] R. Cai, J. Ren, M. Guo, et al., “Dynamic Intracellular Exchange of Nanomaterials′ protein Corona Perturbs Proteostasis and Remodels Cell Metabolism,” Proceedings of the National Academy of Sciences of the United States of America 119 (2022): e2200363119.

[176] J. Chen, Y. Zhu, C. Wu, and J. Shi, “Engineering Lactate-modulating Nanomedicines for Cancer Therapy,” Chemical Society Reviews 52 (2023): 973-1000.

[177] L. Wang, J. Li, Y. Zheng, et al., “Sonodynamic Therapy-based Dual Blockade of Glucose Metabolism Strategy for Pancreatic Cancer Treatment,” Chemical Engineering Journal 507 (2025): 160180.

[178] B. Yang and J. Shi, “Chemistry of Advanced Nanomedicines in Cancer Cell Metabolism Regulation,” Advanced Science 7 (2020): 2001388.

[179] D. Wen, J. Wang, G. V. D. Driessche, et al., “Adipocytes as Anticancer Drug Delivery Depot,” Matter 1 (2019): 1203-1214.

[180] J. Forestier and M. D. Paris, “Rheumatoid Arthritis and Its Treatment by Gold Salts,” The Lancet 224 (1934): 646-648.

[181] W. Wu, L. Yu, Q. Jiang, et al., “Enhanced Tumor-Specific Disulfiram Chemotherapy by in Situ Cu 2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition,” Journal of the American Chemical Society 141 (2019): 11531-11539.

[182] W. Wu, L. Yu, Y. Pu, H. Yao, Y. Chen, and J. Shi, “Copper-Enriched Prussian Blue Nanomedicine for in Situ Disulfiram Toxification and Photothermal Antitumor Amplification,” Advanced Materials 32 (2020): 2000542.

[183] Y. Yan, X. Yang, N. Han, et al., “Metal-organic Framework-encapsulated Dihydroartemisinin Nanoparticles Induces Apoptotic Cell Death in Ovarian Cancer by Blocking ROMO1-mediated ROS Production,” Journal of Nanobiotechnology 21 (2023): 204.

[184] L. Jiang, A. Wu, L. Zeng, et al., “A Slimming/Excavating Strategy for Enhanced Intratumoral Penetration of Acid-Disassemblable NO-Releasing Nanomedicines,” Advanced Healthcare Materials 14 (2025): 2404085.

[185] H. Lu, B. Liang, A. Hu, et al., “Engineered Biomimetic Cancer Cell Membrane Nanosystems Trigger Gas-Immunometabolic Therapy for Spinal-Metastasized Tumors,” Advanced Materials 37 (2025): 2412655.

[186] J. Zhang, P. Wang, M. Zhou, et al., “Gasotransmitter-Nanodonor for Spatial Regulation of Anxiety-Like Behavior and Bone Metastasis,” Advanced Materials 37 (2025): 2416481.

[187] D. Chen, Z. Wu, C. Xia, H. Yang, W. Ding, and Q. He, “A Sustained H 2 /Fluorouracil-Releasing Suppository for High-Efficacy and Low-Toxicity Hydrogenochemotherapy of Colon Cancer,” Advanced Healthcare Materials 14 (2025): 2404054.

[188] J. Wang, H. Yue, X. Huang, and M. Zhang, “Novel Nano-platinum Induces Autophagy Through Dual Pathways in the Treatment of Osteosarcoma in Cell Lines With Different P53 Expression Patterns,” Chemical Engineering Journal 488 (2024): 151071.

[189] H. Wang, W. Sun, D. Zhou, et al., “Hydrogel-immobilized Nanotherapeutics: Inhibition of Protective Autophagy to Amplify STING Signals for Postsurgical Tumor Immunotherapy,” Chemical Engineering Journal 480 (2024): 148211.

[190] M. Li, D. Zhao, J. Yan, et al., “A Redox-Triggered Autophagy-Induced Nanoplatform With PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy,” American Chemical Society Nano 18 (2024): 12870-12884.

[191] Y. Wang, S.-L. Qiao, J. Wang, et al., “Engineered CpG-Loaded Nanorobots Drive Autophagy-Mediated Immunity for TLR9-Positive Cancer Therapy,” Advanced Materials 36 (2024): 2306248.

[192] N. Man, Y. Chen, F. Zheng, W. Zhou, and L.-P. Wen, “Induction of Genuine Autophagy by Cationic Lipids in Mammalian Cells,” Autophagy 6 (2010): 449-454.

[193] K. Peynshaert, S. J. Soenen, B. B. Manshian, et al., “Coating of Quantum Dots Strongly Defines Their Effect on Lysosomal Health and Autophagy,” Acta Biomaterialia 48 (2017): 195-205.

[194] R. Chavez-Dominguez, M. Perez-Medina, J. S. Lopez-Gonzalez, M. Galicia-Velasco, and D. Aguilar-Cazares, “The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity,” Frontiers in Oncology 10 (2020): 578418.

[195] J. Y. Guo, B. Xia, and E. White, “Autophagy-Mediated Tumor Promotion,” Cell 155 (2013): 1216-1219.

[196] D. T. Vogl, E. A. Stadtmauer, K.-S. Tan, et al., “Combined Autophagy and Proteasome Inhibition,” Autophagy 10 (2014): 1380-1390.

[197] N. Shukla, B. Singh, H.-J. Kim, M.-H. Park, and K. Kim, “Combinational Chemotherapy and Photothermal Therapy Using a Gold Nanorod Platform for Cancer Treatment,” Particle & Particle Systems Characterization 37 (2020): 2000099.

[198] Q. Wang, W. Qian, Y. Han, et al. Nature Nanotechnology (2025), https://doi.org/10.1038/s41565-025-01907-2.

[199] V. S. Viswanathan, M. J. Ryan, H. D. Dhruv, et al., “Dependency of a Therapy-resistant state of Cancer Cells on a Lipid Peroxidase Pathway,” Nature 547 (2017): 453-457.

[200] W. Xu, J. Qian, G. Hou, et al., “A Hollow Amorphous Bimetal Organic Framework for Synergistic Cuproptosis/Ferroptosis/Apoptosis Anticancer Therapy via Disrupting Intracellular Redox Homeostasis and Copper/Iron Metabolisms,” Advanced Functional Materials 32 (2022): 2205013.

[201] J. Couzin-Frankel, “Cancer Immunotherapy,” Science 342 (2013): 1432-1433.

[202] X. Sun, X. Zhou, X. Shi, et al., “Strategies for the Development of Metalloimmunotherapies,” Nature Biomedical Engineering 8 (2024): 1073-1091.

[203] C. Feng, P. Tan, G. Nie, and M. Zhu, “Biomimetic and Bioinspired Nano-Platforms for Cancer Vaccine Development,” Exploration 3 (2023): 20210263.

[204] D. Hirayama, T. Iida, and H. Nakase, “The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis,” International Journal of Molecular Sciences 19 (2018): 92.

[205] H. L. Herd, K. T. Bartlett, J. A. Gustafson, L. D. McGill, and H. Ghandehari, “Macrophage Silica Nanoparticle Response Is Phenotypically Dependent,” Biomaterials 53 (2015): 574-582.

[206] H. Fu, L. Wang, Q. Bao, D. Ni, P. Hu, and J. Shi, “Acid Neutralization and Immune Regulation by Calcium-Aluminum-Layered Double Hydroxide for Osteoporosis Reversion,” Journal of the American Chemical Society 144 (2022): 8987-8999.

[207] O. R. Mahon, D. C. Browe, T. Gonzalez-Fernandez, et al., “Nano-particle Mediated M2 Macrophage Polarization Enhances Bone Formation and MSC Osteogenesis in an IL-10 Dependent Manner,” Biomaterials 239 (2020): 119833.

[208] L. Zhao, Y. Gui, J. Cai, and X. Deng, “Biometallic Ions and Derivatives: A New Direction for Cancer Immunotherapy,” Molecular Cancer 24 (2025): 17.

[209] Y. Shi, M. Wu, S. Ge, et al., “Advanced Functional Electromagnetic Shielding Materials: A Review Based on Micro-Nano Structure Interface Control of Biomass Cell Walls,” Nano-Micro Letters 17 (2024): 3.

[210] Q. Feng, W. Fang, Y. Guo, P. Hu, and J. Shi, “Nebulized Therapy of Early Orthotopic Lung Cancer by Iron-Based Nanoparticles: Macrophage-Regulated Ferroptosis of Cancer Stem Cells,” Journal of the American Chemical Society 145 (2023): 24153-24165.

[211] B. Li, Y. Tan, J. H. Lei, et al., “Alkaline Adjuvant Regulates Proteolytic Activity of Macrophages for Antigen Cross-Presentation and Potentiates Radioimmunotherapy,” Advanced Materials 37 (2025): 2416690.

[212] H. Zhu, C. Xu, Y. Geng, Y. Shen, and N. Qiu, “Endoplasmic Reticulum-Targeted Polymer-Manganese Nanocomplexes for Tumor Immunotherapy,” American Chemical Society Nano 19 (2025): 4959-4972.

[213] K. Matsuo, O. Yoshie, K. Kitahata, M. Kamei, Y. Hara, and T. Nakayama, “Recent Progress in Dendritic Cell-Based Cancer Immunotherapy,” Cancers 13 (2021): 2495.

[214] H. Dong, Q. Li, Y. Zhang, M. Ding, Z. Teng, and Y. Mou, “Biomaterials Facilitating Dendritic Cell-Mediated Cancer Immunotherapy,” Advanced Science 10 (2023): 2301339.

[215] X. Zeng, Z. Wang, A. Zhao, et al., “Zinc Nanoparticles From Oral Supplements Accumulate in Renal Tumours and Stimulate Antitumour Immune Responses,” Nature Materials 24 (2025): 287-296.

[216] M. Tan, G. Cao, R. Wang, et al., “Metal-ion-chelating Phenylalanine Nanostructures Reverse Immune Dysfunction and Sensitize Breast Tumour to Immune Checkpoint Blockade,” Nature Nanotechnology 19 (2024): 1903-1913.

[217] Y. Jia, J. Hu, C. Zhu, et al., “Engineered NanoAlum From Aluminum Turns Cold Tumor Hot for Potentiating Cancer Metalloimmunotherapy,” Journal of Controlled Release 354 (2023): 770-783.

[218] T. Guan, Z. Chen, X. Wang, et al., “Harnessing Mn2+ Ions and Antitumor Peptides: A Robust Hydrogel for Enhanced Tumor Immunotherapy,” Journal of the American Chemical Society 147 (2025): 6523-6535.

[219] C. Loftus, M. Saeed, D. M. Davis, and I. E. Dunlop, “Activation of Human Natural Killer Cells by Graphene Oxide-Templated Antibody Nanoclusters,” Nano Letters 18 (2018): 3282-3289.

[220] M. Saxena, S. H. van der Burg, C. J. M. Melief, and N. Bhardwaj, “Therapeutic Cancer Vaccines,” Nature Reviews Cancer 21 (2021): 360-378.

[221] L. Miao, L. Li, Y. Huang, et al., “Delivery of mRNA Vaccines With Heterocyclic Lipids Increases Anti-tumor Efficacy by STING-mediated Immune Cell Activation,” Nature Biotechnology 37 (2019): 1174-1185.

[222] N.-N. Zhang, X.-F. Li, Y.-Q. Deng, et al., “A Thermostable mRNA Vaccine Against COVID-19,” Cell 182 (2020): 1271-1283.e16.

[223] S. Du, J. Yan, Y. Xue, Y. Zhong, and Y. Dong, “Adoptive Cell Therapy for Cancer Treatment,” Exploration 3 (2023): 20210058.

[224] F. Hou, Z. Guo, M. T. Ho, Y. Hui, and C.-X. Zhao, “Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy,” American Chemical Society Nano 18 (2024): 8571-8599.

[225] F. Li, J. Ouyang, Z. Chen, et al., “Nanomedicine for T-Cell Mediated Immunotherapy,” Advanced Materials 36 (2024): 2301770.

[226] L. Yang, Y. Yang, J. Zhang, et al., “Sequential Responsive Nano-PROTACs for Precise Intracellular Delivery and Enhanced Degradation Efficacy in Colorectal Cancer Therapy,” Signal Transduction and Targeted Therapy 9 (2024): 275.

[227] L. J. van der Aa, P. Vader, G. Storm, R. M. Schiffelers, and J. F. J. Engbersen, “Optimization of Poly(amido amine)s as Vectors for siRNA Delivery,” Journal of Controlled Release 150 (2011): 177-186.

[228] S. C. Semple, A. Akinc, J. Chen, et al., “Rational Design of Cationic Lipids for siRNA Delivery,” Nature Biotechnology 28 (2010): 172-176.

[229] M. M. Billingsley, N. Singh, P. Ravikumar, R. Zhang, C. H. June, and M. J. Mitchell, “Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering,” Nano Letters 20 (2020): 1578-1589.

[230] S. D. Jo, G.-H. Nam, G. Kwak, Y. Yang, and I. C. Kwon, “Harnessing Designed Nanoparticles: Current Strategies and Future Perspectives in Cancer Immunotherapy,” Nano Today 17 (2017): 23-37.

[231] B. R. Olden, Y. Cheng, J. L. Yu, and S. H. Pun, “Cationic Polymers for Non-viral Gene Delivery to human T Cells,” Journal of Controlled Release 282 (2018): 140-147.

[232] Y.-Q. Xie, H. Arik, L. Wei, et al., “Redox-responsive Interleukin-2 Nanogel Specifically and Safely Promotes the Proliferation and Memory Precursor Differentiation of Tumor-reactive T-cells,” Biomaterials Science 7 (2019): 1345-1357.

[233] Q. Chen, Q. Hu, E. Dukhovlinova, et al., “Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells,” Advanced Materials 31 (2019): 1900192.

[234] D. Viswanath, J. Park, R. Misra, et al., “Nanotechnology-Enhanced Radiotherapy and the Abscopal Effect: Current Status and Challenges of Nanomaterial-Based Radio-Immunotherapy,” WIREs Nanomedicine Nanobiotechnology 16 (2024): e1924.

[235] L.-P. Zhao, R.-R. Zheng, X.-N. Rao, et al., “Chemotherapy-Enabled Colorectal Cancer Immunotherapy of Self-Delivery Nano-PROTACs by Inhibiting Tumor Glycolysis and Avoiding Adaptive Immune Resistance,” Advanced Science 11 (2024): 2309204.

[236] R. Wang, J. Li, X. Wang, et al., “Personalized Nanovaccines Enhance Lymph Node Accumulation and Reprogram the Tumor Microenvironment for Improved Photodynamic Immunotherapy,” Nano Letters 24 (2024): 7432-7442.

[237] W. Zhong, W. Yuan, Y. Chen, et al., “Activable Nano-Immunomodulator Assembled From π-Extended Naphthalenediimide for Precision Photothermal Immunotherapy,” Angewandte Chemie International Edition 63 (2024): e202401250.

[238] Y. Wang, Q. Tang, R. Wu, et al., “Metformin-Mediated Fast Charge-Reversal Nanohybrid for Deep Penetration Piezocatalysis-Augmented Chemodynamic Immunotherapy of Cancer,” American Chemical Society Nano 18 (2024): 6314-6332.

[239] M. Xu, Y. Hu, J. Wu, J. Liu, and K. Pu, “Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy,” Journal of the American Chemical Society 146 (2024): 34669-34680.

[240] L. Chen, W. Ren, Q. Bao, et al., “Combined Mild Magnetic Hyperthermia and Calcium Ion Regulation for Enhanced Immunotherapy of Orthotopic Liver Cancer,” Nano Today 56 (2024): 102284.

[241] X.-X. Chen, K. Peng, X. Chen, et al., “Microtubule Polymerization Induced by Iridium-Fullerene Photosensitizers for Cancer Immunotherapy via Dual-Reactive Oxygen Species Regulation Strategy,” Aggregate 5 (2024): e623.

[242] S. S. Lucky, K. C. Soo, and Y. Zhang, “Nanoparticles in Photodynamic Therapy,” Chemical Reviews 115 (2015): 1990-2042.

[243] G. Canavese, A. Ancona, L. Racca, et al., “Nanoparticle-assisted Ultrasound: A Special Focus on Sonodynamic Therapy Against Cancer,” Chemical Engineering Journal 340 (2018): 155-172.

[244] Y. Wang, Z. Chen, J. Li, et al., “A Paramagnetic Metal-Organic Framework Enhances Mild Magnetic Hyperthermia Therapy by Downregulating Heat Shock Proteins and Promoting Ferroptosis via Aggravation of Two-Way Regulated Redox Dyshomeostasis,” Advanced Science 11 (2024): 2306178.

[245] S. Wang, W. Jiao, B. Yan, et al., “Intracellular Magnetic Hyperthermia Enables Concurrent Down-Regulation of CD47 and SIRPα To Potentiate Antitumor Immunity,” Nano Letters 24 (2024): 2894-2903.

[246] R. Gupta, A. Chauhan, T. Kaur, B. K. Kuanr, and D. Sharma, “Enhancing Magnetic Hyperthermia Efficacy Through Targeted Heat Shock Protein 90 Inhibition: Unveiling Immune-Mediated Therapeutic Synergy in Glioma Treatment,” American Chemical Society Nano 18 (2024): 17145-17161.

[247] S. Wang, Y. Jiang, Z. Qian, et al., “Prolonged Blood Circulation and Enhanced Tumor Penetration of Biomimetic Magnetic Nanoemulsion for Improved Magnetic Hyperthermia in Combination With Immunotherapy,” Chemical Engineering Journal 488 (2024): 151072.

[248] X. Han, S. Sun, N. Yang, et al., “Nano-Engineered Magnesium Implants for Magnetothermal Enhanced Pyroptosis to Boost Immunotherapy,” Advanced Functional Materials 34 (2024): 2405836.

[249] K. Maier-Hauff, F. Ulrich, D. Nestler, et al., “Efficacy and Safety of Intratumoral Thermotherapy Using Magnetic Iron-oxide Nanoparticles Combined With External Beam Radiotherapy on Patients With Recurrent Glioblastoma Multiforme,” Journal of Neuro-Oncology 103 (2011): 317-324.

[250] Z. Yang, D. Gao, J. Zhao, et al., “Thermal Immuno-nanomedicine in Cancer,” Nature Reviews Clinical Oncology 20 (2023): 116-134.

[251] T. J. Carter, G. Agliardi, F.-Y. Lin, et al., “Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation,” Small 17 (2021): 2005241.

[252] S. M. Levitz and D. T. Golenbock, “Beyond Empiricism: Informing Vaccine Development Through Innate Immunity Research,” Cell 148 (2012): 1284-1292.

[253] Y. Huai, M. N. Hossen, S. Wilhelm, R. Bhattacharya, and P. Mukherjee, “Nanoparticle Interactions With the Tumor Microenvironment,” Bioconjugate Chemistry 30 (2019): 2247-2263.

[254] M. Overchuk and G. Zheng, “Overcoming Obstacles in the Tumor Microenvironment: Recent Advancements in Nanoparticle Delivery for Cancer Theranostics,” Biomaterials 156 (2018): 217-237.

[255] M. Liang and X. Yan, “Nanozymes: From New Concepts, Mechanisms, and Standards to Applications,” Accounts of Chemical Research 52 (2019): 2190-2200.

[256] L. Gao, J. Zhuang, L. Nie, et al., “Intrinsic Peroxidase-Like Activity of Ferromagnetic Nanoparticles,” Nature Nanotechnology 2 (2007): 577-583.

[257] K. Fan, C. Cao, Y. Pan, et al., “Magnetoferritin Nanoparticles for Targeting and Visualizing Tumour Tissues,” Nature Nanotechnology 7 (2012): 459-464.

[258] L. Gao, K. Fan, and X. Yan, “Iron Oxide Nanozyme: A Multifunctional Enzyme Mimetic for Biomedical Applications,” Theranostics 7 (2017): 3207-3227.

[259] B. Xu, H. Wang, W. Wang, et al., “A Single-Atom Nanozyme for Wound Disinfection Applications,” Angewandte Chemie 131 (2019): 4965-4970.

[260] N. Singh, M. A. Savanur, S. Srivastava, P. D'Silva, and G. Mugesh, “A Redox Modulatory Mn 3 O 4 Nanozyme With Multi-Enzyme Activity Provides Efficient Cytoprotection to Human Cells in a Parkinson's Disease Model,” Angewandte Chemie 129 (2017): 14455-14459.

[261] Y. Zhang, F. Wang, C. Liu, et al., “Nanozyme Decorated Metal-Organic Frameworks for Enhanced Photodynamic Therapy,” American Chemical Society Nano 12 (2018): 651-661.

[262] G. Yang, L. Xu, Y. Chao, et al., “Hollow MnO2 as a Tumor-microenvironment-responsive Biodegradable Nano-platform for Combination Therapy Favoring Antitumor Immune Responses,” Nature Communications 8 (2017): 902.

[263] C. Yao, W. Wang, P. Wang, M. Zhao, X. Li, and F. Zhang, “Near-Infrared Upconversion Mesoporous Cerium Oxide Hollow Biophotocatalyst for Concurrent pH-/H2O2-Responsive O2-Evolving Synergetic Cancer Therapy,” Advanced Materials 30 (2018): 1704833.

[264] C. Liu, L. Guo, Y. Wang, J. Zhang, and C. Fu, “Delivering Metal Ions by Nanomaterials: Turning Metal Ions Into Drug-Like Cancer Theranostic Agents,” Coordination Chemistry Reviews 494 (2023): 215332.

[265] A. Kashtiaray, M. Karimi, M. Ghafori-Gorab, and A. Maleki, “A Comprehensive Review on the Recent Applications of Nanozymes in Breast Cancer Therapy and Diagnosis,” Materials Advances 6 (2025): 3017-3042.

[266] G. Yang, J. Ji, and Z. Liu, “Multifunctional MnO2 Nanoparticles for Tumor Microenvironment Modulation and Cancer Therapy,” WIREs Nanomedicine Nanobiotechnology 13 (2021): e1720.

[267] P. Prasad, C. R. Gordijo, A. Z. Abbasi, et al., “Multifunctional Albumin-MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response,” American Chemical Society Nano 8 (2014): 3202-3212.

[268] C. R. Gordijo, A. Z. Abbasi, M. A. Amini, et al., “Design of Hybrid MnO2-Polymer-Lipid Nanoparticles With Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment,” Advanced Functional Materials 25 (2015): 1858-1872.

[269] Y. Matsumura and H. Maeda, “A New Concept for Macromolecular Therapeu-tics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs,” Cancer Research 46 (1986): 6387-6392.

[270] J. Wu, “The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application,” Journal of Personalized Medicine 11 (2021): 771.

[271] H. Hurwitz, L. Fehrenbacher, W. Novotny, et al., “Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer,” New England Journal of Medicine 350 (2004): 2335-2342.

[272] M. I. Setyawati, C. Y. Tay, B. H. Bay, and D. T. Leong, “Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin,” American Chemical Society Nano 11 (2017): 5020-5030.

[273] N. Ni, W. Wang, Y. Sun, X. Sun, and D. T. Leong, “Inducible Endothelial Leakiness in Nanotherapeutic Applications,” Biomaterials 287 (2022): 121640.

[274] F. Peng, M. I. Setyawati, J. K. Tee, et al., “Nanoparticles Promote in Vivo Breast Cancer Cell Intravasation and Extravasation by Inducing Endothelial Leakiness,” Nature Nanotechnology 14 (2019): 279-286.

[275] X. He, Y. Yang, Y. Han, et al., “Extracellular Matrix Physical Properties Govern the Diffusion of Nanoparticles in Tumor Microenvironment,” Proceedings of the National Academy of Sciences of the United States of America 120 (2023): e2209260120.

[276] M. J. Paszek, N. Zahir, K. R. Johnson, et al., “Tensional Homeostasis and the Malignant Phenotype,” Cancer Cell 8 (2005): 241-254.

[277] M. J. Ernsting, B. Hoang, I. Lohse, et al., “Targeting of Metastasis-promoting Tumor-associated Fibroblasts and Modulation of Pancreatic Tumor-associated Stroma With a Carboxymethylcellulose-docetaxel Nanoparticle,” Journal of Controlled Release 206 (2015): 122-130.

[278] L. Miao, Y. Wang, C. M. Lin, et al., “Nanoparticle Modulation of the Tumor Microenvironment Enhances Therapeutic Efficacy of Cisplatin,” Journal of Controlled Release 217 (2015): 27-41.

[279] M. G. Vander Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation,” Science 324 (2009): 1029-1033.

[280] E. Boedtkjer and S. F. Pedersen, “The Acidic Tumor Microenvironment as a Driver of Cancer,” Annual Review of Physiology 82 (2020): 103-126.

[281] J. Zhang, Z. Shi, X. Xu, Z. Yu, and J. Mi, “The Influence of Microenvironment on Tumor Immunotherapy,” Febs Journal 286 (2019): 4160-4175.

[282] S. Karimi, R. Bakhshali, S. Bolandi, et al., “For and Against Tumor Microenvironment: Nanoparticle-based Strategies for Active Cancer Therapy,” Materials Today Bio 31 (2025): 101626.

[283] S.-D. Li and L. Huang, “Pharmacokinetics and Biodistribution of Nanoparticles,” Molecular Pharmaceutics 5 (2008): 496-504.

[284] J. Lu, X. Gao, S. Wang, et al., “Advanced Strategies to Evade the Mononuclear Phagocyte System Clearance of Nanomaterials,” Exploration 3 (2023): 20220045.

[285] C. Yang and D. Merlin, “Challenges to Safe Nanomedicine Treatment,” Nanomaterials 13 (2023): 1171.

[286] F. Ciccarese, V. Raimondi, E. Sharova, M. Silic-Benussi, and V. Ciminale, “Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells,” Antioxidants 9 (2020): 211.

[287] Z. Yu, R. Lou, W. Pan, N. Li, and B. Tang, “Nanoenzymes in Disease Diagnosis and Therapy,” Chemical Communications 56 (2020): 15513-15524.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI and John Wiley & Sons Australia, Ltd.